Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

Disease Sites:

Not Available

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Jallouk, Andrew

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

09-19-2024

Trial Type:

Treatment

Protocol ID:

VICC-XDCTT23452

National Clinical Trial ID:

NCT05776160

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available